TABLE 4.2.
Reference | Type of Implant | Brand name |
Peñarrocha‐Diago, 2000 5 | Endosseous—Tissue level Titanium Plasma Sprayed (TPS) | ITI (Straumann) |
Peñarrocha, Ramblas, 2007 20 | ||
Peñarrocha, 2007 21 | ||
Lee, 2007 22 |
Endosseous—Tissue level titanium sandblasted/acid‐etched (SLA) surface |
Straumann standard plus |
Larrazabal, 2009 8 |
Endosseous—Tissue level Titanium Avanblast Surface—Self‐tapping |
Defcone TSA |
Oliveira, 2010 23 |
Endosseous—Bone level TPS + Hydroxyapatite (HA) |
IMZ twin implants |
Peñarrocha, 2011 25 |
Endosseous—Tissue level Chemically modified / SLA surface |
Phibo TSA Avanblast surface/ITI SLA surface |
Peñarrocha, 2012 26 | ||
Agustín‐Panadero, 2015 27 |
Endosseou—Tissue level chemically modified |
Phibo TSA Avanblast surface |
Guzman, 2016 28 |
Endosseous—Tissue level—self‐tapping Titanium—TMX surface (physical surface features) HA MP1 covering (chemically modified surface) |
Zimmer TSV |
Agustín‐Panadero, 2017 29 |
Endosseous—Tissue level Titanium grade II—chemically modified |
Phibo TSA Avanblast surface |
Molina, 2017 30 |
Endosseous—Tissue level Self‐tapping‐ chemically modified—Mini‐implants |
Not reported |
Agustín‐Panadero, 2019 31 |
Endosseous—Tissue level Titanium grade II—chemically modified |
Phibo TSA Avanblast surface |